Sign in / Join Now
ETFs & Funds
, great stock! The largest
firms are involved. Cash rich, no debt. Rolapitant to get approved in 2013! Get in early!
Add a reply...
Latest StockTalks »
people get TSRO breaking news and analysis by email alert.
Get email alerts on TSRO »
Get latest price
From other sites
Tesaro Announces Opening Of Niraparib Expanded Access Program For U.S. Patients With Ovarian Cancer
at TheStreet (Tue, 8:01AM)
TESARO Varubi IV Gets Complete Response Letter in the U.S.
at Zacks.com (Fri, 7:42AM)
TESARO Receives Complete Response Letter For Rolapitant IV From U.S. FDA
at TheStreet (Wed, 11:30PM)
Tesaro Announces Priority Review Designation For Niraparib NDA
at TheStreet (Dec 20, 2016)
Tesaro Announces Participation In Three Investor Conferences
at TheStreet (Nov 21, 2016)